Ahmed Abudeif Abdelaal

مدرس - مدرس وإستشاري أمراض الكبد والجهاز الهضمي والحميات ومناظير الجهاز الهضمي

كلية الطب

العنوان: قسم طب المناطق الحارة والجهاز الهضمي - مستشفى سوهاج الجامعي - الدور الثالث - المبنى المجاني



السلام عليكم ورحمة الله وبركاته

مرحباً بكم في موقعي الشخصي

2019-09-13 00:22:14
بدء العام الجامعي الجديد
سوف يبدأ بإذن الله تعالى العام الجامعي الجديد يوم 22/9/2019 إقراء المزيد

2019-08-03 11:57:20
إمتحانات الشفوي والكلينيكال في مادة أمراض الباطنة
سوف يتم عقد إمتحانات الشفوي والكلينيكال في مادة أمراض الباطنة يوم الإثنين 9/9/2019 إقراء المزيد

2019-08-03 11:52:06
إمتحانات نهاية العام في مادة الأمراض الباطنة للفرقة الخامسة
سوف تبدأ إمتحانات نهاية العام لمادة الأمراض الباطنة للفرقة الخامسة يوم الخميس الموافق 8/8/2019 إقراء المزيد

2021-01-06 22:09:02 | الكلمات المفتاحية Tp53,
Study the Role of Tp53 in the Development of Hepatocellular Carcinoma in HCV Infected Patients
Background: Hepatocellular carcinoma (HCC) is considered as the primary malignancy of the liver that usually occurs on top of chronic viral hepatitis. The TP53 (tumor protein 53) is a tumor suppressor gene which is the key in tumor development and progression and the single nucleotide polymorphism (SNP) of the p53 gene codon 72 (p53Arg/Pro) changes the structure of the protein. ... إقراء المزيد

2020-08-21 19:32:03 | الكلمات المفتاحية Immune checkpoint inhibitors,
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma A New Era in Treatment of Advanced Disease
ABSTRACT Hepatocellular carcinoma (HCC) is the most prevalent primary hepatic cancer with high fatality and recurrence rates. The prognosis of advanced HCC is dismal, and treatment was limited for a decade to sorafenib with limited effectiveness and miserable overall survival. The advent of immune checkpoint inhibitors (ICPIs) provides a considerable step in the treatment of several advanced malignancies including HCC ... إقراء المزيد

2019-09-13 00:07:21 | الكلمات المفتاحية Globocan 2018, HCC, Epidemiology, HCV, Egypt,
Epidemiology and Risk Factors of Hepatocellular Carcinoma in Egypt
Hepatocellular carcinoma (HCC) is the most prevalent primary cancer of the liver accounting for 75% to 85% of primary liver cancers worldwide. It is the sixth most prevalent cancer in the globe and the fourth most prevalent cause of death from cancer, it occurs in males 2 to 3 times higher than in females. Geographical distribution of HCC varies throughout ... إقراء المزيد

2019-02-18 12:47:15 | الكلمات المفتاحية Liver disease, VITAMIN D, HCC, HCV,
Vitamin D and Hepatitis C Virus-related Liver Disease
ABSTRACT Vitamin D through the vitamin D receptor (VDR) is involved in the control of bone and calcium homeostasis, immunoregulation, cellular differentiation, and anti-inflammatory actions. The liver is central in vitamin D synthesis, however the direct involvement of the vitamin D with chronic liver disease, chronic hepatitis C (CHC) infection, and hepatocellular carcinoma (HCC) remains to be evaluated. The purpose ... إقراء المزيد

2019-02-18 12:49:32 | الكلمات المفتاحية SNP, VDR, HCC,
VDR Gene Polymorphisms and Risk of Hepatocellular Carcinoma
ABSTRACT Hepatocellular carcinoma (HCC) is the sixth most common cancer in the world and the fourth most common cause of cancer death. The development of HCC is a complex and multi-factorial process, in which both environmental and genetic features interfere and contribute to malignant transformation. Numerous genetic studies have reported associations between single nucleotide polymorphisms (SNPs) and the presence of ... إقراء المزيد